Haizheng Pharmaceuticals obtained a registration approval for Acapo sugar drug.

Guide: Acapo sugar tablets are suitable for the treatment of type 2 diabetes, also applies to reduce the sugar tolerance of low-food blood sugar !---- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .January 31, 2019, the Drug Review Center of the State Drug Administration accepted the company's application for registration of acapo sugar tablets.acapo saccharine tablets are suitable for the treatment of type 2 diabetes, as well as to reduce post-meal blood sugar in people with low sugar tolerance.Acapo sugar tablets developed by Bayer, the product name "Glucobay ®", first listed in Germany in 1990, approved in Japan in 1993, Bayer PharmaAG production of Acapo sugar tablets were first approved for import into China in December 1994, in September 1999 the State Drug Administration approved Bayer Health Care Co., Ltd.'s Acapo sugar tablet production, the product name is ®.at present, there are Hangzhou China-U.S. East China Pharmaceutical Co., Ltd.'s Acapo sugar tablets (50mg, 100mg), Beijing Fuyuan Pharmaceutical Co., Ltd.'s Acapo sugar tablets (50mg) through consistency evaluation;, Sichuan Green Leaf Pharmaceutical Co., Ltd.'s Acapo Sugar Capsule (50mg) also passed the consistency evaluation., Acapo sugar tablets sold about $65,536.71 million worldwide in 2019, including about $56,718.95 million in the domestic market, and $16,647.19 million in January-March 2020, of which domestic sales were about $14,543.12 million (data from IMS).so far, the company has invested about RMB15.14 million in the research and development project of Acapo Sugar Tablet..